https://www.thehypemagazine.com/feed/
At this year’s Conference on Retroviruses and Opportunistic Infections in Denver, ViiV Healthcare will outline a future of HIV care increasingly defined by longer dosing intervals, expanded prevention options and data-driven personalization. The global HIV specialist company, majority owned by GSK with Pfizer and Shionogi as shareholders, will present new clinical and real-world findings spanning its established portfolio and next-generation pipeline. Central to the discussion is the evolution t…
続きを読む>>ViiV Advances Ultra Long-Acting HIV Care at CROI
